The mTOR kinase inhibitor everolimus synergistically enhances the anti‐tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS‐123 on Mantle cell lymphomaJiao Li, Jun Zhu|International Journal of Cancer|2017Cited by 29